LFST

Robert Bessler

Known title: DirectorCIK: 0001864881

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 10, 2026

Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.

this person other insiders at LFST

Transaction History

LFST▲ Buy$0
LFST▼ Sell$4.5M
LFST▼ Sell$4.5M
LFST▼ Sell$2.3M
LFST▼ Sell$2.3M
LFST▼ Sell$321K
LFST▼ Sell$321K
LFST▼ Sell$219K
LFST▼ Sell$219K
LFST▼ Sell$27K
LFST▼ Sell$27K
LFST▼ Sell$18K
LFST▼ Sell$18K
LFST▼ Sell$6K
LFST▼ Sell$6K
LFST▼ Sell$422K
LFST▼ Sell$422K
LFST▼ Sell$23K
LFST▼ Sell$23K
LFST▼ Sell$43K
LFST▼ Sell$43K
LFST▼ Sell$279K
LFST▼ Sell$279K
LFST▲ Buy$0
LFST▼ Sell$17K
LFST▼ Sell$17K
LFST▼ Sell$49
LFST▼ Sell$49
LFST▼ Sell$283K
LFST▼ Sell$283K
LFST▲ Buy$0
LFST▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.